|
Kyung Dong Pharmaceutical Company Ltd - Comparative Business Analysis Snapshot
Business Description
Kyung Dong Pharmaceutical Company Ltd. The Company's principal activities are manufacturing and selling of pharmaceutical products for multiple therapeutic fields. The Company's two main product groups include finished compounds, including acetaminophen, roxithromycin, acyclovir, ofloxacin, dihydroergocristine methanesulfonate, metformin, levosulpiride, dihydroxyaluminum allantoinate, domperidone maleate, ambroxol and other products, and raw bulk materials, comprised of difemerine hydrochloride, tiropramide hydrochloride, cilostazol, aceclofenac, levofloxacin, nizatidine and rebamipide. In addition, the Company is engaged in the sale of animal drugs and sports related products, among others. Kyungdong Pharmaceutical's products are exported to international customers in Brazil, Cambodia, Chile, Colombia, Costa Rica, India, Japan, Jordan, Pakistan, the Republic of Yemen, Spain, Sudan, Syria and Vietnam.
Competitor Analysis
This analysis compares Kyung Dong Pharmaceutical Company Ltd with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
